Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.

Androgen-deprivation therapy (ADT) is standard treatment for locally advanced or metastatic prostate cancer (PCa). Many patients develop castration resistance (castration-resistant PCa [CRPC]) after approximately 2-3 yr, with a poor prognosis. The molecular mechanisms underlying CRPC progression are...

Full description

Bibliographic Details
Main Authors:	Rajan, P, Sudbery, I, Villasevil, M, Mui, E, Fleming, J, Davis, M, Ahmad, I, Edwards, J, Sansom, O, Sims, D, Ponting, C, Heger, A, McMenemin, R, Pedley, I, Leung, H
Format:	Journal article
Language:	English
Published:	2014

Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.

Similar Items